Financial Year |
March 31 2023 |
Monetary Funds |
722,119,049.85 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
20,843,730.14 |
Accounts Receivable |
1,956,758,323.88 |
Advances to Suppliers |
16,584,471.92 |
Other Receivables |
8,251,192.54 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
339,492,231.06 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
32,716,090.69 |
Total Current Assets |
3,096,765,090.08 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
15,625,595.07 |
Investment Properties |
-- |
Fixed Assetes |
158,360,097.08 |
Under-construction Projects |
1,964,042.00 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
11,664,417.38 |
R&D expenses |
-- |
Goodwill |
25,214,760.47 |
Long-Term Deferred and Prepaid Expenses |
46,794,089.88 |
Deferred Income Tax Assets |
36,363,670.96 |
Other Non-Current Assets |
13,505,225.78 |
Sub-Total of Non-Current Assets |
365,778,834.14 |
Total Assets |
3,462,543,924.22 |
Short-Term Loans |
159,273,143.60 |
Trading Financial liabilities |
-- |
Notes Payable |
105,505,627.21 |
Accounts Payable |
599,900,237.27 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
115,653,668.13 |
Taxes Payable |
43,622,228.33 |
Interest Payable |
-- |
Dividend Payable |
5,880,000.00 |
Other payables |
68,221,314.59 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
16,195,132.70 |
Other Current Liabilities |
723,591.18 |
Sub-Total of Current Liabilities |
1,117,622,235.23 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
54,818,024.04 |
Total Liabilities |
1,172,440,259.27 |
Paid-In Capital(Or Share Stock) |
400,517,000.00 |
Capital Surplus |
553,960,781.01 |
Surplus Reserve |
86,525,659.79 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
1,043,675,127.72 |
Minority Stockholder's Interest |
205,425,096.43 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,084,678,568.52 |
Owner's Equity(Stockholder's Equity) |
2,290,103,664.95 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
3,462,543,924.22 |